Audrey Clary-Laroche

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression.

Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 13, 2024

Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas.

Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 23, 2023

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications.

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications.

Journal: Experimental hematology & oncology

Published: December 27, 2022

Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study.

Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study.

Journal: Cancer communications (London, England)

Published: April 17, 2022

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting.

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting.

Journal: Cancers

Published: September 10, 2020

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies.

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies.

Journal: Cancers

Published: June 22, 2020

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.

Journal: EBioMedicine

Published: April 19, 2020

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications.

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications.

Journal: Cancers

Published: February 02, 2020

Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.

Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.

Journal: Journal of hematology & oncology

Published: November 23, 2019

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.

Journal: Scientific reports

Published: August 06, 2019

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.

Journal: Journal of hematology & oncology

Published: September 15, 2018

CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.

CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 07, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026